Title: Deletion of E184L, a Putative DIVA Target from the Pandemic Strain of African Swine Fever Virus, Produces a Reduction in Virulence and Protection against Virulent Challenge

Journal Article · · Journal of Virology
 [1];  [2];  [3];  [1];  [1];  [4];  [5];  [1];  [5];  [1]; ORCiD logo [1]
  1. US Dept. of Agriculture (USDA), Greenport, NY (United States). Agricultural Research Service (ARS), Plum Island Animal Disease Center
  2. US Dept. of Agriculture (USDA), Greenport, NY (United States). Agricultural Research Service (ARS), Plum Island Animal Disease Center; Mississippi State Univ., Starkville, MS (United States)
  3. US Dept. of Agriculture (USDA), Greenport, NY (United States). Agricultural Research Service (ARS), Plum Island Animal Disease Center; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
  4. US Dept. of Agriculture (USDA), Greenport, NY (United States). Agricultural Research Service (ARS), Plum Island Animal Disease Center; Kansas State Univ., Manhattan, KS (United States)
  5. Univ. Autonoma de Barcelona, Bellaterra (Spain). Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB)

African swine fever (ASF) is currently causing a major pandemic affecting the swine industry and protein availability from Central Europe to East and South Asia. No commercial vaccines are available, making disease control dependent on the elimination of affected animals. Here, we show that the deletion of the African swine fever virus (ASFV) E184L gene from the highly virulent ASFV Georgia 2010 (ASFV-G) isolate produces a reduction in virus virulence during the infection in swine. Of domestic pigs intramuscularly inoculated with a recombinant virus lacking the E184L gene (ASFV-GDE184L), 40% experienced a significantly (5 days) delayed presentation of clinical disease and, overall, had a 60% rate of survival compared to animals inoculated with the virulent parental ASFV-G. Importantly, all animals surviving ASFV-G-DE184L infection developed a strong antibody response and were protected when challenged with ASFV-G. As expected, a pool of sera from ASFV-G-DE184L-inoculated animals lacked any detectable antibody response to peptides partially representing the E184L protein, while sera from animals inoculated with an efficacious vaccine candidate, ASFV-GDMGF, strongly recognize the same set of peptides. These results support the potential use of the E184L deletion for the development of vaccines able to differentiate infected from vaccinated animals (DIVA). Therefore, it is shown here that the E184L gene is a novel ASFV determinant of virulence that can potentially be used to increase safety in preexisting vaccine candidates, as well as to provide them with DIVA capabilities. To our knowledge, E184L is the first ASFV gene product experimentally shown to be a functional DIVA antigenic marker.

Research Organization:
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDA; USDOE Office of Science (SC)
Grant/Contract Number:
SC0014664
OSTI ID:
1983351
Journal Information:
Journal of Virology, Journal Name: Journal of Virology Journal Issue: 1 Vol. 96; ISSN 0022-538X
Publisher:
American Society for MicrobiologyCopyright Statement
Country of Publication:
United States
Language:
English

References (37)

African Swine Fever Virus book January 2009
A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs journal March 2020
African Swine Fever Virus MGF-110-9L-deficient Mutant Has Attenuated Virulence in Pigs journal March 2021
Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88/3 decreases its ability to protect against challenge with virulent virus journal August 2013
African swine fever virus Georgia isolate harboring deletions of 9GL and MGF360/505 genes is highly attenuated in swine but does not confer protection against parental virus challenge journal August 2016
Gene expression analysis of whole blood RNA from pigs infected with low and high pathogenic African swine fever viruses journal August 2017
CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses journal February 2018
Development of a fluorescent ASFV strain that retains the ability to cause disease in swine journal April 2017
GARD: a genetic algorithm for recombination detection journal November 2006
Not So Different After All: A Comparison of Methods for Detecting Amino Acid Sites Under Selection journal February 2005
Pfam: The protein families database in 2021 journal October 2020
A Simple Method of Estimating Fifty per cent Endpoints12 journal May 1938
Identification of the principal serological immunodeterminants of African swine fever virus by screening a virus cDNA library with antibody journal June 2002
Preclinical Diagnosis of African Swine Fever in Contact-Exposed Swine by a Real-Time PCR Assay journal January 2005
A Cell Culture-Adapted Vaccine Virus against the Current African Swine Fever Virus Pandemic Strain journal June 2021
African Swine Fever Virus Georgia Isolate Harboring Deletions of MGF360 and MGF505 Genes Is Attenuated in Swine and Confers Protection against Challenge with Virulent Parental Virus journal March 2015
African Swine Fever Virus Georgia 2007 with a Deletion of Virulence-Associated Gene 9GL (B119L), when Administered at Low Doses, Leads to Virus Attenuation in Swine and Induces an Effective Protection against Homologous Challenge journal June 2015
BA71ΔCD2: a New Recombinant Live Attenuated African Swine Fever Virus with Cross-Protective Capabilities journal August 2017
A Proteomic Atlas of the African Swine Fever Virus Particle journal December 2018
Simultaneous Deletion of the 9GL and UK Genes from the African Swine Fever Virus Georgia 2007 Isolate Offers Increased Safety and Protection against Homologous Challenge journal January 2017
Development of a Highly Effective African Swine Fever Virus Vaccine by Deletion of the I177L Gene Results in Sterile Immunity against the Current Epidemic Eurasia Strain journal March 2020
The Progressive Adaptation of a Georgian Isolate of African Swine Fever Virus to Vero Cells Leads to a Gradual Attenuation of Virulence in Swine Corresponding to Major Modifications of the Viral Genome journal December 2014
A Nonessential African Swine Fever Virus Gene UK Is a Significant Virulence Determinant in Domestic Swine journal February 1998
An African Swine Fever Virus ERV1-ALRHomologue, 9GL, Affects Virion Maturation and Viral Growth in Macrophages and Viral Virulence in Swine journal February 2000
Detecting Individual Sites Subject to Episodic Diversifying Selection journal July 2012
CRISPR/Cas Gene Editing of a Large DNA Virus: African Swine Fever Virus journal January 2018
Genomic Analysis of Highly Virulent Georgia 2007/1 Isolate of African Swine Fever Virus journal April 2011
Identification and Immunogenicity of African Swine Fever Virus Antigens journal June 2019
First Oral Vaccination of Eurasian Wild Boar Against African Swine Fever Virus Genotype II journal April 2019
Protective Properties of Attenuated Strains of African Swine Fever Virus Belonging to Seroimmunotypes I–VIII journal April 2020
Differential Effect of the Deletion of African Swine Fever Virus Virulence-Associated Genes in the Induction of Attenuation of the Highly Virulent Georgia Strain journal July 2019
Deletion of CD2-Like (CD2v) and C-Type Lectin-Like (EP153R) Genes from African Swine Fever Virus Georgia-∆9GL Abrogates Its Effectiveness as an Experimental Vaccine journal October 2020
Deletion of the L7L-L11L Genes Attenuates ASFV and Induces Protection against Homologous Challenge journal February 2021
ASFV-G-∆I177L as an Effective Oral Nasal Vaccine against the Eurasia Strain of Africa Swine Fever journal April 2021
Association of the Host Immune Response with Protection Using a Live Attenuated African Swine Fever Virus Model journal October 2016
Generation and Evaluation of an African Swine Fever Virus Mutant with Deletion of the CD2v and UK Genes journal December 2020
African Swine Fever Virus MGF-505-7R Negatively Regulates cGAS–STING-Mediated Signaling Pathway journal March 2021